Evaluation of primary lung carcinoma using technetium 99m-hexamethylpropylene amine oxime: preliminary clinical experience
- 1 December 1990
- journal article
- research article
- Published by Springer Nature in European Journal of Nuclear Medicine and Molecular Imaging
- Vol. 16 (12) , 859-864
- https://doi.org/10.1007/bf01280252
Abstract
99mTc-labelled hexamethylpropylene amine oxime (HMPAO) is a lipophilic compound with a neutral charge which reflects tumor blood flow and has been previously investigated to estimate brain blood flow. In this study, we attempted to use99mTc-HMPAO for the evaluation of 18 patients with histologically proven primary lung carcinoma. The eight surgical specimens revealed that viable carcinoma cells were present when the99mTc-HMPAO accumulated in the tumor, however, extensive tumor necrosis was observed when defective or ring like uptake was seen in the tumor. Qualitative study revealed that when perfusion defects were observed corresponding to the tumor, the possibility of squamous cell carcinoma or large cell carcinoma was high instead of adenocarcinoma. Quantitative analysis revealed that the uptake ratio was statistically different between adenocarcinoma (1.6±0.1) and squamous cell carcinoma (1.2±0.4) (PPP99mTc-HMPAO may be useful for the evaluation of patients with primary lung carcinoma.Keywords
This publication has 13 references indexed in Scilit:
- Tc-99m Hexamethylpropylene-amine Oxine (HM-PAO) Uptake in a Bone MetastasisClinical Nuclear Medicine, 1988
- Initial experience with Tc-99m-HM-PAO in the study of brain tumorsEuropean Journal of Nuclear Medicine and Molecular Imaging, 1988
- INITIAL EXPERIENCE WITH TC-99M HMPAO BRAIN SPECT1987
- HM-PAO assessment of human tumour perfusionEuropean Journal of Cancer and Clinical Oncology, 1987
- 99mTc-HMPAO as a tumour blood flow agentEuropean Journal of Nuclear Medicine and Molecular Imaging, 1987
- Tomographic studies of rCBF with99mTc-HM-PAO SPECT in comparison with PET in patients with primary brain tumorsNeurosurgical Review, 1987
- Cerebral and cerebellar uptake of 99mTc-(d,1)-hexamethyl-propyleneamine oxime (HM-PAO) in patients with brain tumor studied by single photon emission computerized tomographyEuropean Journal of Nuclear Medicine and Molecular Imaging, 1986
- Development of a 99Tcm-labelled radiopharmaceutical for cerebral blood flow imagingNuclear Medicine Communications, 1985